Circular RNAs in renal cell carcinoma: Functions in tumorigenesis and diagnostic and prognostic potentials

Arezou Sayad1, Sajad Najafi2, Amir Hossein Kashi3

  • 1Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

Circular RNAs (circRNAs) are key regulators in cell processes. This review explores their roles in renal cell carcinoma (RCC), highlighting their potential as diagnostic and prognostic biomarkers for cancer.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Circular RNAs (circRNAs) are covalently closed non-coding RNA molecules resistant to exonucleases.
  • They exhibit cell- and tissue-specific expression patterns.
  • circRNAs play crucial roles in regulating gene expression and cellular functions, including cell cycle and proliferation.

Purpose of the Study:

  • To review the tumorigenic and tumor-suppressing roles of circRNAs in renal cell carcinoma (RCC).
  • To assess the diagnostic and prognostic potential of circRNAs in RCC.
  • To explore circRNAs as potential biomarkers for RCC diagnosis and prognosis.

Main Methods:

  • Literature review of studies investigating circRNAs in RCC.
  • Analysis of high-throughput data identifying differentially expressed circRNAs in RCC.
  • Evaluation of the correlation between circRNA expression and clinicopathological features, prognosis, and survival in RCC patients.

Main Results:

  • Dysregulated circRNAs are implicated in RCC carcinogenesis.
  • Overexpressed circRNAs can promote tumorigenic functions, while down-regulated circRNAs may repress them.
  • Aberrant circRNA expression correlates with clinicopathological features, prognosis, and survival in RCC patients, indicating diagnostic and prognostic value.

Conclusions:

  • circRNAs possess significant tumorigenic or tumor-suppressing effects in RCC.
  • circRNAs demonstrate potential as valuable biomarkers for RCC diagnosis and prognosis.
  • Further research into circRNAs could lead to novel therapeutic strategies for RCC.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.3K